Header Logo

Connection

SANJAY MEDIWALA to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications SANJAY MEDIWALA has written about Antineoplastic Agents.
SANJAY MEDIWALA
Connection Strength
0.068
Antineoplastic Agents
  1. CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy. Horm Cancer. 2016 06; 7(3):196-210.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.